MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transac

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' l

Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the impact of tari

SNY's $9.5 billion deal to acquire BPMC boosts its immunology pipeline and adds fast-growing Ayvakit

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) for possible br

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

The deal announced Monday is Sanofi's third of the year so far.

The deal includes a drug approved in the U.S. and the EU for systemic mastocytosis, a rare immunolog

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

NEW YORK--(BUSINESS WIRE)-- #AI--VantAI, a leader in generative AI and proximity-based therapeutics,

BMPC's first-quarter earnings and sales miss estimates. However, shares rally on raised Ayvakit sale

Blueprint Medicines Corporation (NASDAQ:BPMC ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM

Blueprint Medicines (BPMC) came out with a quarterly loss of $0.74 per share versus the Zacks Consen

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral t

  During Monday's trading, 1214 companies set new 52-week lows.

  Friday's session saw 466 companies set new 52-week highs.

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday

Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018